2 peptides in this category
A novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously....
First-in-class dual GIP/GLP-1 receptor agonist (Mounjaro®/Zepbound®) achieving up to 22.5% weight lo...